A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management

被引:38
作者
Neinstein, Aaron [1 ,2 ]
Wong, Jenise [3 ,4 ]
Look, Howard [5 ]
Arbiter, Brandon [5 ]
Quirk, Kent [5 ]
McCanne, Steve [5 ]
Sun, Yao [3 ]
Blum, Michael [1 ,2 ]
Adi, Saleh [3 ,4 ]
机构
[1] Univ Calif San Francisco, Dept Med, 400 Parnassus Ave,Suite A550, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Digital Hlth Innovat, 400 Parnassus Ave,Suite A550, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pediat, 400 Parnassus Ave,Suite A550, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Madison Clin Pediat Diabet, 400 Parnassus Ave,Suite A550, San Francisco, CA 94143 USA
[5] Tidepool, Palo Alto, CA USA
关键词
diabetes mellitus type 1; insulin infusion systems; blood glucose self-monitoring; mobile applications; decision making; computer-assisted; GLYCEMIC CONTROL; SOFTWARE-DEVELOPMENT; PUMP THERAPY; INTERVENTION; PANCREAS; BUSINESS; CHILDREN;
D O I
10.1093/jamia/ocv104
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective Develop a device-agnostic cloud platform to host diabetes device data and catalyze an ecosystem of software innovation for type 1 diabetes (T1D) management. Materials and Methods An interdisciplinary team decided to establish a nonprofit company, Tidepool, and build open-source software. Results Through a user-centered design process, the authors created a software platform, the Tidepool Platform, to upload and host T1D device data in an integrated, device-agnostic fashion, as well as an application ("app"), Blip, to visualize the data. Tidepool's software utilizes the principles of modular components, modern web design including REST APIs and JavaScript, cloud computing, agile development methodology, and robust privacy and security. Discussion By consolidating the currently scattered and siloed T1D device data ecosystem into one open platform, Tidepool can improve access to the data and enable new possibilities and efficiencies in T1D clinical care and research. The Tidepool Platform decouples diabetes apps from diabetes devices, allowing software developers to build innovative apps without requiring them to design a unique back-end (e.g., database and security) or unique ways of ingesting device data. It allows people with T1D to choose to use any preferred app regardless of which device(s) they use. Conclusion The authors believe that the Tidepool Platform can solve two current problems in the T1D device landscape: 1) limited access to T1D device data and 2) poor interoperability of data from different devices. If proven effective, Tidepool's open source, cloud model for health data interoperability is applicable to other healthcare use cases.
引用
收藏
页码:324 / 332
页数:9
相关论文
共 63 条
[1]  
Adi Saleh, 2010, Adolesc Med State Art Rev, V21, P86
[2]   Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial [J].
Amiel, S ;
Beveridge, S ;
Bradley, C ;
Gianfrancesco, C ;
Heller, S ;
James, P ;
McKeown, N ;
Newton, D ;
Newton, L ;
Oliver, L ;
Reid, H ;
Roberts, S ;
Robson, S ;
Rollingson, J ;
Scott, V ;
Speight, J ;
Taylor, C ;
Thompson, G ;
Turner, E ;
Wright, F .
BRITISH MEDICAL JOURNAL, 2002, 325 (7367) :746-749
[4]  
[Anonymous], MED DEV INT SAF PATH
[5]  
[Anonymous], DIABETES SPECTRUM
[6]  
[Anonymous], LEAN LAUNCHPAD LIFE
[7]  
[Anonymous], 2014, NAT DIAB STAT REP ES
[8]  
[Anonymous], HLTH INF PERS 20601
[9]  
[Anonymous], NIST SPEC PUBL NAT I
[10]  
[Anonymous], FDA APPROVAL ANIMAS